Identification of Gefitinib Resistance-Related lncRNA-miRNA-mRNA Regulatory Networks and Corresponding Prognostic Signature in Patients with Lung Adenocarcinoma.

Wang, Taoli; Wu, Zhulin; Li, Shiguang; Chen, Zhong; Chen, Yiqi; Yang, Zhenjiang

Wang, Taoli; Wu, Zhulin; Li, Shiguang; Chen, Zhong; Chen, Yiqi; Yang, Zhenjiang.

Afiliação

Wang T; Department of Oncology, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, People's Republic of China.
Wu Z; Department of Oncology, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, People's Republic of China.
Li S; Department of Oncology, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, People's Republic of China.
Chen Z; Department of Oncology, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, People's Republic of China.
Chen Y; Department of Oncology, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, People's Republic of China.
Yang Z; Department of Oncology, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, People's Republic of China.

Int J Gen Med ; 15: 7155-7168, 2022.

Article em En | MEDLINE | ID: mdl-36118184